Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
VAALCO Energy, Inc. (NYSE: EGY) shares spiked 19.06 percent to close at $7.12 a share Friday. The stock traded between $6.19 and $7.25 on volume 2.26 million shares traded. The company reported a net income of $26.4 million, or $0.46 per diluted share, for the fourth quarter of 2013, compared to a net loss of $18.9 million, or $0.33 per diluted share, a year ago. Shares of VAALCO Energy are down approximately 3.0 percent year-to-date.
Get more information on VAALCO Energy free access to the in-depth equity report at:
Coffee Holding Co., Inc. (NASDAQ: JVA) shares soared 19.97 percent to close at $7.99 a share Friday. The stock traded between $7.11 and $8.20 on volume 2.90 million shares traded. The company reported a net income of $1.37 million, or $0.21 per diluted share, for the fourth quarter of 2013, compared to $937,537, $0.14 per diluted share, a year ago. Shares of Coffee Holding Co. are up approximately 56.0 percent year-to-date.
Get more information on Coffee Holding Co. and free access to the in-depth equity report at:
NewLead Holdings Ltd. (NASDAQ: NEWL) shares surged 17.41 percent to close at $3.44 a share Friday. The stock traded between $3.17 and $4.25 on volume of 7.67 million shares traded. The company announced that it has acquired two eco-type 31,800 dwt, Handysize bulk carriers built in 2012 for a total acquisition price of $37.0 million. On March 6th, NewLead Holdings announced a 1 for 10 reverse split of common shares.
Get more information on NewLead Holdings and free access to the in-depth equity report at:
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) shares jumped 15.46 percent to close at $4.63 a share Friday. The stock traded between $3.98 and $4.80 on volume of 1.93 million shares traded. The company recently announced that the American Journal of Physiology has published recent research results with its orally-bioavailable AMPK activator, R118. Shares of Rigel Pharmaceuticals are up approximately 60.0 percent year-to-date.
Get more information on Rigel Pharmaceuticals and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities